Peptide purity standards for medicines track every impurity above 0.1%, while research figures such as ≥95%, ≥98% and ≥99% are supplier specifications that only mean something with a method and a batch number.
Last updated 27 October 2026 · Written by the SHLabz research team
Research peptide listings are full of numbers. One says “≥95%”, another says “≥98%”, a third says “99.4%”. Most people assume the highest number wins. In practice, those numbers are not always comparable, and some of them describe nothing you can check.
Meanwhile, the rules for medicines are far stricter. European regulators report peptide-related impurities above 0.1%, identify them above 0.5% and qualify them above 1.0%. This guide explains what the research tiers mean, how they differ from pharmacopoeial rules, why purity is not content, and how to read one real certificate.
Quick answer: Peptide purity standards differ by context. Medicines follow pharmacopoeial rules, such as the European Pharmacopoeia’s 0.1%, 0.5% and 1.0% impurity thresholds. Research peptides have no binding standard, so ≥95%, ≥98% or ≥99% are supplier specifications. Each figure only means something alongside its HPLC method, an identity result and a batch number that matches your vial, ideally from an independent laboratory such as Janoshik.
What Peptide Purity Standards Measure
Almost every peptide purity figure comes from high-performance liquid chromatography, or HPLC. The instrument separates a sample into components, and a UV detector records each one as a peak. Purity is the area of the main peak divided by the total area of all peaks.
So “98.7% purity” means the main peak made up 98.7% of the signal. That is useful. However, it has limits. An impurity that runs inside the main peak is invisible. Likewise, anything the detector cannot see, such as water or most salts, never enters the sum.
For this reason, the method matters as much as the result. A different column, gradient or wavelength can split impurities apart or hide them. Our HPLC testing explainer shows how to read a chromatogram.
Research Tiers and Peptide Purity Standards
Research suppliers usually sort products into tiers. These tiers are conventions, not regulations. Still, they help you judge what a listing is claiming.
- ≥95%. A common minimum for general research use. It allows up to 5% of the detected signal to come from other components.
- ≥98%. Common among suppliers selling a higher grade. It needs more purification, so it costs more and yields less.
- 99% or more. Usually quoted for individual batches rather than as a minimum. Even so, it is only as good as its method.
What the Tiers Do Not Tell You
None of these tiers says which impurities are present. A sample at 98% with one 2% impurity differs from a sample at 98% with twenty tiny ones. In addition, the tiers say nothing about identity, content or water.
Pharmacopoeial Peptide Purity Standards
Medicines are a different world. Here, peptide purity standards come from pharmacopoeias and regulators, and they focus on individual impurities rather than one headline figure.
European Rules
Peptides are excluded from the ICH Q3A impurity guideline, so European regulators refer to the European Pharmacopoeia’s general monograph “Substances for pharmaceutical use” (2034). According to a 2026 review of the EMA’s new guideline on synthetic peptides, peptide-related impurities are reported above 0.1%, identified above 0.5% and qualified above 1.0%. The same review notes that limits must rest on batch history and process knowledge, not copied thresholds.
US Rules
In the United States, the FDA’s 2021 guidance on certain synthetic peptide generics asks applicants to identify each peptide-related impurity at 0.10% or more. It also expects any new specified impurity to stay at or below 0.5%. Meanwhile, the United States Pharmacopeia publishes chapter <1503> on quality attributes of synthetic peptide drug substances, plus chapters on acetic acid and trifluoroacetic acid in peptides.
Research-Grade vs Pharmacopoeial Peptide Purity Standards
The gap between the two is large. On one side, a pharmacopoeial standard sets rules for individual impurities, validated methods and documented manufacturing. On the other side, a research-grade figure is usually one HPLC number, measured by one laboratory, on one batch.
That does not make research figures worthless. Instead, read them for what they are. A research peptide marked 99% has not been shown to meet any monograph, and no certification body sets purity standards for research-use peptides. Our guide to what a certified peptide supplier can mean covers labels and badges.
Furthermore, the literature shows why independent checks matter. In a 2015 study in the Journal of Pharmaceutical Analysis, researchers ordered 98 peptides specified at ≥95%. All arrived with certificates claiming that figure. Yet only 43 met it in the team’s own testing, and none of the nine cyclic peptides exceeded 90%.
Purity Is Not Net Peptide Content
Purity tells you how clean the peptide is. Content tells you how much peptide is in the vial at all. Specifically, lyophilised peptides usually carry counter-ions, such as acetate or trifluoroacetate, left over from purification. They also hold some water. Neither shows up as a peak in a typical UV purity run.
As a result, a vial can test at 99% purity while the peptide itself weighs noticeably less than the label mass. Therefore, content needs a separate measurement. Our guide to net peptide content walks through the arithmetic.
Reading One Certificate
For example, our GHK-Cu 100 mg batch SHCU100-082026 shows HPLC purity of 99.713%, analysed on 25 August 2026. It also reports measured content of 86.10 mg, split into GHK 75.14 mg and copper 10.96 mg. Put simply, purity is the main peak as a share of all peaks detected. By contrast, content is the measured mass in the vial. Therefore, the two answer different questions.
- Purity in context. 99.713% sits above every research tier, but it is still one figure under one method, for one batch.
- Content in context. 86.10 mg in a 100 mg vial shows why label mass and measured mass differ.
- Verification. Janoshik Analytical issued the report, and our lab results page links to Janoshik’s own record through a “Verify” button.
That said, not every product has a published certificate yet. The current list covers 13 products across 16 batches: SH-R, GHK-Cu, BPC-157, TB-500, MOTS-c, NAD+, KLOW Blend, CJC-1295 (no DAC), Ipamorelin, Tesamorelin, Selank, Epithalon and GLOW Blend. An independent laboratory tests every batch, and all batch figures are in the open SHLabz Purity Index.
How to Compare Claims Against Peptide Purity Standards
Sooner or later, you will see two listings for the same compound with different numbers. Here is a simple way to compare them.
- Find the batch. First, check that each figure has a batch number. A figure without one drops out of the comparison.
- Find the method. Next, look for the HPLC conditions and the chromatogram.
- Find the identity result. Then check for a mass spectrometry result that matches the expected mass.
- Find the laboratory. After that, see whether an independent laboratory issued the report, and whether you can verify it.
- Compare the numbers. Only now compare the purity figures that passed every step.
- Match on arrival. Finally, check that the batch on your vial matches the certificate you compared.
Often, this changes the answer. A documented 98.6% tells you more than an undocumented 99.9%. Our peptide batch testing guide covers the matching step.
A Supplier Checklist for Peptide Purity Standards
- No method. First, a figure with no column, gradient or wavelength cannot be judged.
- No chromatogram. Next, without the trace you cannot see small peaks or shoulders.
- No batch number. The figure might describe a batch sold out months ago.
- No identity result. A clean peak could belong to the wrong compound.
- No laboratory. Then check for a named issuer you can contact.
- No verification route. A report with no link or code cannot be confirmed.
- Purity sold as content. A listing implies 99% purity means 99% peptide by weight.
- “Pharmaceutical grade” with no paperwork. Finally, the phrase implies a monograph the seller cannot document.
Why Researchers Order From SHLabz
- Every batch tested. An independent laboratory tests every batch; Janoshik certificates carry a “Verify” link.
- Purity and content shown. Published certificates report both, so you can see the difference.
- Every format, packed cold. Vials, pens, nasal sprays, serums and hair sprays, under cold chain in the UAE.
- Same-day or next-day in the UAE. Order before 12:00 UAE time for same-day delivery, or after 12:00 for next-day; remote areas take 1–3 working days. AED 15, free over AED 350.
- GCC and Jordan. Vials and topicals in 2–4 working days, AED 60, free over AED 2,500.
Our storage guide explains why sealed powder travels well, and why pens and nasal sprays stay in the UAE.
The Short Version
Figures such as ≥95%, ≥98% and ≥99% are supplier specifications for research peptides, not legal or pharmacopoeial standards. Medicines follow far stricter peptide purity standards that track individual impurities from 0.1% upwards.
Purity is not content. Moreover, a purity figure only means something with a stated method, an identity result and a batch number that matches your vial.
Frequently Asked Questions
What is a good purity for a research peptide? Many research suppliers quote ≥98% or ≥99%. However, the method and the batch matter more than the headline number, so read the certificate behind it.
Are there official peptide purity standards for research peptides? No binding standard exists for research-use peptides. Pharmacopoeial standards, such as the European Pharmacopoeia’s, apply to medicines.
Is 99% purity the same as 99% peptide in the vial? No. Purity compares peaks in an HPLC run. Content measures how much peptide is actually in the vial, after counter-ions and water.
Why do two certificates for the same peptide show different purity? They probably describe different batches, or the laboratory used different methods.
What does “pharmaceutical grade” mean for a research peptide? Strictly, it means meeting a pharmacopoeial standard under documented manufacturing. A research listing using the phrase without that documentation is making a claim you cannot check.
Who sets peptide purity standards for medicines? Pharmacopoeias such as the European Pharmacopoeia and the United States Pharmacopeia publish them. Regulators then apply them when they assess a medicine.
Does a higher purity figure make a peptide approved? No. Purity is an analytical measurement. In the UAE, approval is a regulatory decision under Federal Decree-Law No. 38 of 2024, and retatrutide, for example, remains investigational with no UAE approval.
References
- EMA’s New Guideline for Synthetic Peptides: A More Explicit CMC Playbook for a Growing Therapeutic Class — Pharmaceutical Online, 2026. On the Ph. Eur. 2034 reporting, identification and qualification thresholds.
- ANDAs for Certain Highly Purified Synthetic Peptide Drug Products That Refer to Listed Drugs of rDNA Origin — US FDA, May 2021. On the 0.10% identification and 0.5% new-impurity figures.
- Peptide-related USP-NF Documentary Standards and USP Reference Standards — United States Pharmacopeia, December 2023. Lists chapter <1503> and the acetic acid and TFA chapters.
- Quality evaluation of synthetic quorum sensing peptides used in R&D — Verbeke et al., Journal of Pharmaceutical Analysis, 2015. On the gap between certificate claims and measured purity.
- Janoshik Analytical — janoshik.com. States that every report is verifiable via its Verify tab or QR code.
Regulation in this area moves quickly. This article offers general information rather than legal advice, so anyone making a procurement decision with legal consequences should confirm the current position independently.
Finally, the catalogue lists every product with its batch details, and our contact page reaches the team on WhatsApp and email, Monday to Friday, 9:00 AM to 6:00 PM.
This article is provided for general research and educational purposes only. All SHLabz products are sold strictly for laboratory research use and are not intended for human or veterinary consumption, diagnosis, treatment, or prevention of any disease. Nothing in this article constitutes medical advice. Always consult a qualified professional and comply with applicable local regulations regarding the handling and use of research compounds.






